AIM
AIM ImmunoTech

34,517
Loading...
Loading...
News
all
press releases
News Placeholder
FibroGen (FGEN) Reports Q2 Loss, Lags Revenue Estimates
FibroGen (FGEN) delivered earnings and revenue surprises of -50.22% and -53.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week
New trial data, a reverse split, and financing moves triggered a spike in retail chatter for these biotech stocks in the week ending Feb. 28, 2025.
Stocktwits·6mo ago

Latest AIM News

View

Advertisement. Remove ads.

Advertisement. Remove ads.